Refractory migraine - a review
- PMID: 23405959
- DOI: 10.1111/head.12047
Refractory migraine - a review
Abstract
Refractory migraine has long been a challenge to all headache specialists. This subgroup of migraine patients experience disability and impaired quality of life, despite optimal treatment. This article reviews the proposed definitions and epidemiology of refractory migraine, as well as the pathophysiology that may contribute to the genesis of this disorder. Aspects of treatment, including pharmacological, complementary/adjunct, and invasive approaches, are reviewed. Comorbid factors, medication overuse, potential pitfalls to treatment, and areas for future investigation are highlighted.
© 2013 American Headache Society.
Similar articles
-
Identifying and managing refractory migraine: barriers and opportunities?J Headache Pain. 2019 Aug 23;20(1):89. doi: 10.1186/s10194-019-1040-x. J Headache Pain. 2019. PMID: 31443629 Free PMC article. Review.
-
Toward an epidemiology of refractory migraine: current knowledge and issues for future research.Headache. 2008 Jun;48(6):791-8. doi: 10.1111/j.1526-4610.2008.01131.x. Epub 2008 May 9. Headache. 2008. PMID: 18479422
-
Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society.Headache. 2008 Jun;48(6):778-82. doi: 10.1111/j.1526-4610.2008.01132.x. Epub 2008 May 14. Headache. 2008. PMID: 18484982
-
Behavioral treatment of migraine: current status and future directions.Expert Rev Neurother. 2004 May;4(3):403-13. doi: 10.1586/14737175.4.3.403. Expert Rev Neurother. 2004. PMID: 15853538 Review.
-
Defining refractory migraine: results of the RHSIS Survey of American Headache Society members.Headache. 2009 Apr;49(4):509-18. doi: 10.1111/j.1526-4610.2009.01370.x. Epub 2009 Feb 25. Headache. 2009. PMID: 19245385
Cited by
-
One Patient, Three Providers: A Multidisciplinary Approach to Managing Common Neuropsychiatric Cases.J Clin Med. 2023 Sep 4;12(17):5754. doi: 10.3390/jcm12175754. J Clin Med. 2023. PMID: 37685821 Free PMC article. Review.
-
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial.Headache. 2023 Jan;63(1):79-88. doi: 10.1111/head.14439. Epub 2023 Jan 18. Headache. 2023. PMID: 36651532 Free PMC article. Clinical Trial.
-
Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis.J Headache Pain. 2022 Nov 4;23(1):139. doi: 10.1186/s10194-022-01507-8. J Headache Pain. 2022. PMID: 36333710 Free PMC article.
-
Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study.J Headache Pain. 2021 Oct 2;22(1):114. doi: 10.1186/s10194-021-01333-4. J Headache Pain. 2021. PMID: 34600468 Free PMC article.
-
Ketamine in the Past, Present, and Future: Mechanisms, Metabolites, and Toxicity.Curr Pain Headache Rep. 2021 Jul 16;25(9):57. doi: 10.1007/s11916-021-00977-w. Curr Pain Headache Rep. 2021. PMID: 34269883 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
